glp 1 agonist drug names GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 Free Comparison Chart: GLP-1 and
Description
In: Diabetologia
January 2026: With the creation of an MDL (centralized litigation) for people who experienced vision loss after taking GLP-1 drugs for diabetes or weight loss, patients have a new legal option for filing a court case
At DevotedDOc , we recognize these hurdles and are committed to creating an inclusive telehealth experience that works for everyone regardless of socioeconomic status or location
In addition, the SUMMIT trial evaluates the effect of tirzepatide (the GLP-1/GIP dual receptor agonist) in people with obesity-related HFpEF (Clinicaltrials.gov ID NCT04847557)
The unimolecular dual incretins were more successful than selective monoagonists and tackled the two basic causes of diabetes: pancreatic insulin insufficiency and obesity-induced insulin resistance
Secher A, Jelsing J, Barquero AF, et al
